Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma

Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma

Abstract Background Uterine corpus endometrial carcinoma (UCEC) is a gynecological malignant tumor with high incidence and poor prognosis. Although immunotherapy has brought significant survival benefits to advanced UCEC patients, traditional evaluation indicators cannot accurately identify all pote...

Full description

Bibliographic Details
Main Authors:	Ganghua Zhang, Zhijing Yin, Jianing Fang, Anshan Wu, Guanjun Chen, Ke Cao
Format:	Article
Language:	English
Published:	BMC 2023-06-01
Series:	Cancer Cell International
Subjects:	Uterine corpus endometrial carcinoma CD8+ T cell Immune response Gene mutation NIRS
Online Access:	https://doi.org/10.1186/s12935-023-02966-y

Similar Items

FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma
by: Zhe Wang, et al.
Published: (2023-02-01)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
by: Cankun Zhou, et al.
Published: (2020-11-01)

Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma
by: Qi Zhang, et al.
Published: (2024-02-01)

DEPDC1 is up-regulated in uterine corpus endometrial cancer
by: YANG Tingting, HUANG Jie, GUO Jianxin, HAN Jian
Published: (2023-09-01)

Spectrum of Uterine corpus lesions in hysterectomy specimens
by: Sharadrutha A1 , Janaki M2
Published: (2017-08-01)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
by: Kang He, et al.
Published: (2023-01-01)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
by: Jinhui Liu, et al.
Published: (2021-11-01)

Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma
by: Cong Yu, et al.
Published: (2022-01-01)

Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients
by: Qin Liu, et al.
Published: (2022-11-01)

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis
by: Ye Y, et al.
Published: (2021-11-01)

Comprehensive Analysis of Prognosis and Immune Landscapes Based on Lipid-Metabolism- and Ferroptosis-Associated Signature in Uterine Corpus Endometrial Carcinoma
by: Pusheng Yang, et al.
Published: (2023-02-01)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
by: Yun Chen
Published: (2022-07-01)

Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma
by: Jinhui Liu, et al.
Published: (2021-12-01)

Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
by: Bohan Li, et al.
Published: (2023-12-01)

Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation
by: Yan-Bin Jin, et al.
Published: (2023-07-01)

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
by: Tesfaye Wolde, et al.
Published: (2024-02-01)

The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma
by: Zheng X, et al.
Published: (2021-12-01)

Identification of an endoplasmic reticulum stress-related gene signature to predict prognosis and potential drugs of uterine corpus endometrial cancer
by: Pei Zhou, et al.
Published: (2023-01-01)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
by: Li-Peng Pei, et al.
Published: (2022-06-01)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
by: Shen Xue, et al.
Published: (2023-02-01)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
by: Jianming Tang, et al.
Published: (2022-08-01)

Comprehensive landscape of the functions and prognostic value of RNA binding proteins in uterine corpus endometrial carcinoma
by: Yong Yao, et al.
Published: (2022-10-01)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
by: Sitian Wei, et al.
Published: (2022-09-01)

Discovering common pathogenetic processes between polycystic ovary syndrome and uterine corpus endometrial carcinoma by bioinformatics and experimental approach
by: Mingming Wang, et al.
Published: (2024-02-01)

Endoplasmic reticulum stress related IncRNA signature predicts the prognosis and immune response evaluation of uterine corpus endometrial carcinoma
by: Jun Chen, et al.
Published: (2023-01-01)

CD4+ and CD8+ preimplantation endometrial population in women with unexplained recurrent miscarriage
by: Ahmed Abdelrahim, et al.
Published: (2023-04-01)

Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?
by: Changho Song, et al.
Published: (2023-09-01)

The Expression of Pyroptosis-Related Gene May Influence the Occurrence, Development, and Prognosis of Uterine Corpus Endometrial Carcinoma
by: Xiaoling Huang, et al.
Published: (2022-04-01)

Uncovering a novel DNA repair-related radiosensitivity model for evaluation of radiotherapy susceptibility in uterine corpus endometrial cancer
by: Hainan Yang, et al.
Published: (2024-04-01)

Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes
by: Jinhui Liu, et al.
Published: (2021-10-01)

Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma
by: Chenrui Guo, et al.
Published: (2022-11-01)

Uterin lipoma, leiyomyoma ve endometrial polip birlikteliği
by: Nilgün SÖĞÜTÇÜ, et al.
Published: (2019-09-01)

A bioinformatic analysis of the role of TP53 status on the infiltration of CD8+ T cells into the tumor microenvironment
by: A.A. El-Arabey, et al.
Published: (2023-10-01)

Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
by: Qihui Wu, et al.
Published: (2023-03-01)

Endometrial Cancer Suppresses CD8+ T Cell-Mediated Cytotoxicity in Postmenopausal Women
by: Mickey V. Patel, et al.
Published: (2021-04-01)

Retrospective examination of endometrial sampling results in women with abnormal uterine bleeding
by: Reyhan Aydın Doğan, et al.
Published: (2023-04-01)

Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
by: Samuel H. Jungen, et al.
Published: (2023-03-01)

Abnormal Uterine Bleeding- evaluation by Endometrial Aspiration
by: Pratibha Singh
Published: (2018-01-01)

New Aspects of Sarcomas of Uterine Corpus—A Brief Narrative Review
by: Stoyan Kostov, et al.
Published: (2021-11-01)

Histopathological Study of Endometrial Sampling in Abnormal Uterine Bleeding
by: Dr. Shraddha J Patel, et al.
Published: (2023-06-01)